BBY
48
5
DUK
47
2
UAL
56
2
NAVI
41
12
DGX
48
4
NSC
42
2
ADBE
55
4
KR
55
2
FITB
60
2
HON
58
4
FOX
42
2
PX
25
6
TGNA
56
3
SEE
57
2
MPC
44
14
DHI
54
6
TDC
70
2
NKE
42
2
HP
33
4
SRCL
40
6
BBY
48
5
DUK
47
2
UAL
56
2
NAVI
41
12
DGX
48
4
NSC
42
2
ADBE
55
4
KR
55
2
FITB
60
2
HON
58
4
FOX
42
2
PX
25
6
TGNA
56
3
SEE
57
2
MPC
44
14
DHI
54
6
TDC
70
2
NKE
42
2
HP
33
4
SRCL
40
6
Financhill
Back

AIM ImmunoTech 10K Form

Sell
50

AIM
AIM ImmunoTech

Last Price:
0.41
Seasonality Move:
3.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-05-17 10Q AIM/AIM ImmunoTech Quarterly
2021-03-31 10K AIM/AIM ImmunoTech Annual
2020-11-12 10Q AIM/AIM ImmunoTech Quarterly
2020-08-14 10Q AIM/AIM ImmunoTech Quarterly
2020-05-14 10Q AIM/AIM ImmunoTech Quarterly
2020-03-30 10K AIM/AIM ImmunoTech Annual

Receive AIM News And Ratings

See the #1 stock for the next 7 days that we like better than AIM

AIM Financial Statistics

Sales & Book Value

Annual Sales: $202K
Cash Flow: $-9.96M
Price / Cash Flow: 0
Annual Sales: $0.19
Price / Book: 2.12

Profitability

EPS (TTM): -0.60000
Net Income (TTM): $-28.96M
Gross Margin: $160K
Return on Equity: -106.14%
Return on Assets: -91.19%

AIM ImmunoTech Earnings Forecast

Key AIM ImmunoTech Financial Ratios

  • The Gross Profit Margin over the past 29 years for AIM is 79.21%.
  • The Selling, General & Administrative Expenses for AIM have been equal to 10,463.86% of Gross Profit Margin.
  • The Research & Development expenses have been 5,415.35% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of AIM is -14,337.62% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 17 years.

AIM ImmunoTech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: AIM
CUSIP: 00901B
Website: aimimmuno.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.68
Quick Ratio: 1.65

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AIM Technical Analysis vs Fundamental Analysis

Sell
50
AIM ImmunoTech (AIM) is a Sell

Is AIM ImmunoTech a Buy or a Sell?

  • AIM ImmunoTech stock is rated a Sell
    The current AIM ImmunoTech [AIM] share price is $0.40. The Score for AIM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.